Academic

Chao-Cheng (Chris) Lin
 


peer-review publications (*corresponding author)

1.     Lin, C. C., Akuhata-Huntington, Z., & Hsu, C. W. (2023). Comparing ChatGPT’s ability to rate the degree of stereotypes and the consistency of stereotype attribution with those of medical students in New Zealand in developing a similarity rating test: a methodological study. Journal of Educational Evaluation for Health Professions, 20, 17.

2.     Chien, Y. L., Liu, C. C., Chiu, Y. N., & Lin, C. C. (2023). Assessing emotional characteristics in Asian autistic adults without intellectual disability. Asian Journal of Psychiatry, 82, 103472.

3.     Lin, C. C., & Linscott, R. J. (2022). Longitudinal mediation by perceived burden of the pathway from thwarted belonging to suicidal ideation. Suicide and Life‐Threatening Behavior, 52(6), 1193-1204.

4.     Chen JT, Lin YT, Tseng HH, Lin AS, Chen HC, Bai YM, *Lin CC, The validity of Inventory of Depressive Symptomatology, Self-Report (IDS-SR) and its association with professional help-seeking among individuals with social anxiety disorder. Taiwanese Journal of Psychiatry 2020; 34(4), 188-195.

5.     Tseng HH, Huang YL, Chen JT, Liang KY, *Lin CC, *Chen SH. Facial and prosodic emotion recognition in social anxiety disorder. Cognitive Neuropsychiatry 2017; 22:4, 331-345.

6.     Tseng MC, Tu CY, Chang CH, Lin CC. Comparative validity of the Internet and paper-and-pencil versions of the Night Eating Questionnaire. Comprehensive Psychiatry 2017; 75:53-61.

7.     Cheng KY, Lu TH, Chen TT, Chuang YA, Chen JY, *Lin CC. Natural mortality and late-life risk factors among long-stay psychiatric elders: a case control study. Taiwanese Journal of Psychiatry 2015 Mar; 29(1):40-50.

8.     Yin YC, Lin CC, Chen TT, Chen JY, Tsai HJ, Wang JY, Chen SY. Clozapine Induces Autophagic Cell Death in Non-Small Cell Lung Cancer Cell. Cellular Physiology and Biochemistry 2015; 35:945-956.

9.     Lin CC, Chiu HJ, Chen JY, Liou YJ, Wang YC, Chen TT, Bai YM*. Switching from Clozapine to Zotepine in Patients with Schizophrenia: A 12-week prospective, randomized, rater blind and parallel study. J Clin Psychopharmacol 2013 Apr; 33(2): 211-214.

10. Wu CS, Lin CC, Chang CM, Wu KY, Liang HY, Huang YW, Tsai HJ. Antipsychotic treatment and the occurrence of venous thromboembolism: a 10-year nationwide registry study. J Clin Psychiatry 2013;74: 918-924

11. Lin CC, Wu WC, Liaw HT, Liu CC. Effectiveness of a virtual patient program in a psychiatry clerkship. Medical Education 2012; 46(11): 1111-1112.

12. Lin CC, Yu SC, Wu BJ, Chang DJ. Measurement of waist circumference at different sites affects the detection of abdominal obesity and metabolic syndrome among psychiatric patients. Psychiatry Research 2012 May; 197(3):322-6.

13. Lin HY, Lin CC, Liu CC. Hypomania associated with adjunctive aripiprazole in an elder female with recurrent major depressive disorder: dose-related phenomenon? Journal of Clinical Psychopharmacology 2012; 32(6): 836-7.

14. Chang YJ, Li YC, Hsu CY, Yeh ML, Lin CC, Hsu MS, Chiu WT. Predicting Hospital-Acquired Infections by Scoring System with Simple Parameters. PLoS ONE 2011;6(8): e23137.

15. Chen JT, *Lin CC, Wang SC, Liao SC, Chen JY, Liu CY, Lee MB. Finding Social Phobia Patients from the Internet. Psychiatry research 2011 Nov; 190(1): 121-125.

16. Yu LC, Chan CL, Lin CC, and Lin IC. Mining association language patterns using a distributional semantic model for negative life event classification. J Biomed Inform 2011;44: 509-518.

17. Huang WL, *Lin CC, Liao SC. Leukopenia Related to Haloperidol Add-on Treatment to Olanzapine. Taiwanese Journal of Psychiatry 2011; 25(2): 115-118.

18. Lai IC, Chen ML, Wang YC, Chen JY, Liao DL, Bai YM, Lin CC, Chen TT, Liou YJ. Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia. European Journal of Clinical Pharmacology 2011; 67(4):383-388.

19. Lai IC, Chen ML, Wang YC, Chen JY, Liao DL, Bai YM, Lin CC, Chen TT, Liou YJ. Analysis of genetic variations in the human melatonin receptor (MTNR1A, MTNR1B) genes and antipsychotics-induced tardive dyskinesia in schizophrenia. World J Biol Psychiatry. 2011; 12(2): 143-148.

20. Bai YM, Lin CC, Chen JY, Su TP. Metabolic Syndrome in Inpatients Treated With Clozapine Reply. J Clin Psychiatry 2011; 72(6):873-874.

21. Bai YM, Lin CC, Chen JY, Chen TT, Su TP, Chou P. Association of weight gain and metabolic syndrome in patients taking Clozapine: A 8-year cohort study. J Clin Psychiatry 2011; 72(6):751-756.

22. Lin CC, Bai YM, Chen JY, Hwang TJ, Chen TT, Chiu HW, Li YC. Easy and Low-Cost Identification of Metabolic Syndrome in Patients Treated with Second-Generation Antipsychotics: Artificial Neural Network and Logistic Regression Models. J Clin Psychiatry 2010; 71(3):225-234.

23. Su YH, Luh JJ, Chen HI, Lin CC, Liao MJ, Chen HS. Effects of using relaxation breathing training to reduce music performance anxiety in 3rd to 6th graders. Med Probl Perform Art 2010;25: 82-86.

24. Suzuki Y, Takahashi T, Nagamine M, Zou Y, Cui J, Han B, Park JI, Hwu HG, Chen CC, Lin CC, Shinfuku N. Comparison of psychiatrists’ views on classification of mental disorders in four East Asian countries. Asian Journal of Psychiatry 2010; 3: 20-25.

25. Wang YC, Bai YM, Chen JY, Lin CC, Lai IC, Liou YJ. Genetic association between TNF-alpha -308 G>A polymorphism and longitudinal weight change during clozapine treatment. Hum Psychopharmacol Clin 2010;25: 303-309.

26. Lin CC, Bai YM, MD, Wang YC, Chen TT, Lai IC, Chen JY, Chen SY, Gau SS, Liou YJ. Improved Body Weight and Metabolic Outcomes in Overweight or Obese Psychiatric Patients Switched to Amisulpride from Other Atypical Antipsychotics. J Clin Psychopharmacol 2009; 29(6):520-528.

27. Bai YM, Chen JY, Chen TT, Lin CY, Chou P, Su TP, *Lin CC. Weight gain with clozapine: 8-year cohort naturalistic study among hospitalized Chinese schizophrenia patients. Schizophr Res 2009;108: 122-126.

28. Bai YM, Chen TT, Yang WS, Chi YC, Lin CC, Liou YJ, Wang YC, Su TP, Chou P, Chen JY. Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study. Schizophr Res 2009; 111:1-8.

29. Liou YJ, Chen ML, Wang YC, Chen JY, Liao DL, Bai YM, Lin CC, Chen TT, Mo GH and Lai IC. Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2009;150B: 239-242.

30. Liou YJ, Chen ML, Wang YC, Chen JY, Liao DL, Bai YM, Lin CC, Chen TT, Mo GH and Lai IC. Analysis of genetic variations in the human Par-4 (PAWR) gene and tardive dyskinesia in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2009;150B: 439-440.

31. Lin CCWang YC, Chen JY, Liou YJ, Bai YM, Lai IC, Chen TT, Chiu HW, Li YC. Artificial neural network prediction of clozapine response with combined pharmacogenetic and clinical data. Comput Methods Programs Biomed 2008; 91(2):91-99.

32. Lin CC: Duloxetine treatment of social anxiety disorder with comorbid major depression. J Clin Psychopharmacol 2008; 28(5):591-592.

33. Lin CC, Bai YM, Chen JY, Wang YC, Liou YJ: Treatment of clozapine-associated tardive dyskinesia. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32(2):599-600.

34. Liou YJ, Wang YC, Chen JY, Chen ML, Chen TT, Bai YM, Lin CC, Liao DL, Lai IC. The coding-synonymous polymorphism rs1045280 (Ser280Ser) in beta-arrestin 2 (ARRB2) gene is associated with tardive dyskinesia in Chinese patients with schizophrenia. Eur J Neurol 2008;15: 1406-1408.

35. Lin CC. Psychopharmacological Prediction by artificial neural networks. Taiwanese Journal of Psychiatry 2008; 22(4): 254-67.

36. Bai YM, Chen JY, Yang WS, Chi YC, Liou YJ, Lin CC, Wang YC, Lin CY, Su TP, Chou P: Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia. J Clin Psychiatry 2007; 68(12):1834-1839.

37. Mo GH, Liao DL, Lai IC, Wang YC, Chen JY, Lin CY, Chen ZT, Chen ML, Bai YM, Lin CC, Liou YJ. Support for an association of the C939T polymorphism in the human DRD2 gene with tardive dyskinesia in schizophrenia. Schizophr Res 2007, 97, 302-304.

38. Liou YJ, Wang YC, Chen JY, Bai YM, Lin CC, Liao DL, Chen TT, Chen ML, Mo GH, Lai IC: Association analysis of polymorphisms in the N-methyl-d-aspartate (NMDA) receptor subunit 2B (GRIN2B) gene and tardive dyskinesia in schizophrenia. Psychiatry Res 2007; 153(3):271-275.

39. Lin CC, Bai YM, Liu CY, Hsiao MC, Chen JY, Tsai SJ, Ouyang WC, Wu CH and Li YC. Web-based tools can be used reliably to detect patients with major depressive disorder and subsyndromal depressive symptoms. BMC Psychiatry 2007, 7:12.

40. Bai YM, Lin CC, Chen JY, Lin CY, Su TP, Chou P. Association of Initial Antipsychotic Response to Clozapine and Long-Term Weight Gain. Am J Psychiat 2006; 163:1276-1279.

41. Chen TT, Chen JY, Bai YM, Lin CC: The effects of zotepine in treating psychotic patients with hyperuricaemia: a case series. Int J Neuropsychopharmacol 2006; 9(2):259-261

42. Liou YJ, Lai IC, Liao DL, Chen JY, Lin CC, Lin CY, Chen CM, Bai YM, Chen TT, Wang YC: The human dopamine receptor D2 (DRD2) gene is associated with tardive dyskinesia in patients with schizophrenia. Schizophr Res 2006; 86(1-3):323-325.

43. Liou YJ, Lai IC, Wang YC, Bai YM, Lin CC, Lin CY, Chen TT, Chen JY: Genetic analysis of the human ENTH (Epsin 4) gene and schizophrenia. Schizophr Res 2006; 84(2-3):236-243.

44. Liou YJ, Lai IC, Lin MW, Bai YM, Lin CC, Liao DL, Chen JY, Lin CY, Wang YC: Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and tardive dyskinesia in patients with schizophrenia. Pharmacogenet Genomics 2006; 16(3):151-157.

45. Wang YC, Bai YM, Chen JY, Lin CC, Lai IC, Liou YJ: Polymorphism of the adrenergic receptor alpha 2a -1291C>G genetic variation and clozapine-induced weight gain. J Neural Transm 2005; 112(11):1463-1468.

46. Wang YC, Bai YM, Chen JY, Lin CC, Lai IC, Liou YJ: C825T polymorphism in the human G protein beta3 subunit gene is associated with long-term clozapine treatment-induced body weight change in the Chinese population. Pharmacogenet Genomics 2005; 15(10):743-748.

47. Liou YJ, Wang YC, Lin CC, Bai YM, Lai IC, Liao DL, Chen JY: Association analysis of NAD(P)Hratioquinone oxidoreductase (NQO1) Pro187Ser genetic polymorphism and tardive dyskinesia in patients with schizophrenia in Taiwan. Int J Neuropsychopharmacol 2005; 8(3):483-486.

48. Bai YM, Yu SC, Chen JY, Lin CY, Chou P, Lin CC*: Risperidone for pre-existing severe tardive dyskinesia: a 48-week prospective follow-up study. Int Clin Psychopharmacol 2005; 20(2):79-85.

49. Lai IC, Wang YC, Lin CC, Bai YM, Liao DL, Yu SC, Lin CY, Chen JY, Liou YJ. Negative association between Catechol-O-methyltransferase (COMT) gene Val158Met polymorphism and Persistent Tardive Dyskinesia in Schizophrenia. J Neural Transm 2005; 112(8):1107-1113.

50. Lin CC, Bai YM, Wang YC, Chen JY, Liou YJ, Lin CY, Chueh CM. Artificial Neural Network Prediction of Therapeutic Response to Clozapine with Clinical and Genetic Factors. European Neuropsychopharmacology 2004; 14(Suppl.3):282.

51. Chen J Y, Lin C C, Bai Y M. Satisfaction with eGroups among persons with psychiatric disorders. Psychiatr Serv 2004; (55): 945.

52. Ya-Mei Bai , Lin CC, Chih-Yuan Lin, Jen-Yeu Chen, Ching-Mo Chueh, Win-Chien Liu. Survey of Stress Reactions among Health Care Workers Involved with the SARS Outbreak. Psychiatric Services 2004; 55(9): 1055-1057. 

53. Liou YJ, Wang YC, Bai YM, Lin CC, Yu SC, Liao DL, Lin MW, Chen JY, Lai IC. Cytochrome P-450 2D6*10 C188T polymorphism is associated with antipsychotic-induced persistent tardive dyskinesia in Chinese schizophrenic patients. Neuropsychobiology 2004; (49): 167-173.

54. Wang YC, Liou YJ, Liao DL, Bai YM, Lin CC, Yu SC, Chen JY. Association analysis of a neural nitric oxide synthase genetic polymorphism and antipsychotics-induced tardive dyskinesia in Chinese schizophrenic patients. J Neural Transm. 2004;111(5):623-9.

55. Bai YM, Yu SC, Lin CC*. Risperidone for Severe Tardive Dyskinesia: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study. J Clin Psychiat 2003 Nov; 64(11): 1342-1348.

56. Lin CC, Bai YM, Chen JY. Reliability of information provided by patients of a virtual psychiatric clinic. Psychiat Serv 2003; 54(8):1167-1168.

57. Lai IC, Liao DL, Bai YM, Lin CC, Yu SC, Chen JY, Wang YC. Association study of the estrogen receptor polymorphisms with tardive dyskinesia in schizophrenia. Neuropsychobiology 2002;46(4):173-5. 

58. Bai YM, Lin CC, Chen JY, Liu WC. Virtual psychiatric clinics. American Journal of Psychiatry 2001; 158(7):1160-1.

59. Chen JY, Bai YM, Pyng LY, Lin CC. Risperidone for tardive dyskinesia. American Journal of Psychiatry 2001;158(11):1931-2. 

60. Bai YM, *Lin CC, Chen JY, Liu WC: Therapeutic effect of pirenzepine for clozapine-induced hypersalivation: a randomized, double blind, placebo-controlled, cross-over study. Journal of Clinical Psychopharmacology 2001; 21: 608-11.

61. Bai YM, Lin CC,  Chen JY. Internet Addiction Disorder Among Clients of a Virtual Clinic. Psychiatric Services 2001; 2 (10): 1397.

62. Lin CC. Clozapine-induced urinary incontinence: facts or artefacts? Acta Psychiatrica Scandinavica 2000; 101(5): 410.

63. Bai YM, Huang Y, *Lin CC, Chen JY: Emerging Homosexual Conduct during Hospitalization among Chronic Schizophrenia Patients. Acta Psychiatrica Scandinavica 2000:12:350-353.

64. Hsu JW, Wang YC, Lin CC, Bai YM, Chen JY, Chiu HJ, Tsai SJ, Hong CJ. No evidence for association of alpha 1a adrenoceptor gene polymorphism and clozapine-induced urinary incontinence. Neuropsychobiology 2000; 42(2):62-5.

65. Zhong MX, Lin CC, Hsu JW. The experience and feedback from the pilot interactive group therapy in Yuli Veterans Hospital. Chinese Association of Group Psychotherapy 2000, 6(3): 12-15.

66. Lin CC, Bai YM, Chen JY, Lin JY, Lan TH. A retrospective study of clozapine and urinary incontinence in Chinese in-patients. Acta Psychiatrica Scandinavica 1999;100(2): 158-161.

67. Bai YM, *Lin CC, Chen JY, Ju-Yuan Lin. Weight gain Among Patients on Clozapine. Psychiatric Service 1999; 50:704-5.

68. Lin CC, Bai YM, Hu PG, Yeh HS. Substance Use Disorders among Bipolar Disorder and Major Depression in a General Hospital. General Hospital Psychiatry 1998;20(2): 98-101.

69. Bai YM, *Lin CC, Hu PG, Yeh HS. Risk Factors for Substance Use Disorders among Inpatients with Major AffectiveDisorders in Taiwan Chinese. General Hospital Psychiatry 1998;20(6):377-380.  

70. Bai YM, Liu CY, Lin CC. Risk Factors for Parasuicide Among Psychiatric Inpatients. Psychiatric Services 1997: 48: 1201-1203. 

71. Liu CY, Wang SJ, Teng EL, Fuh JL, Lin CC, Lin KN, Chen HM, Lin CH, Wang PN, Yang YY, Larson EB, Chou P, Liu HC : Depressive disorders among older residents in a Chinese rural community. Psychol Med 1997;27(4):943-949.  

72. Lin CC, CJ Hong. A Case Report of Panhypopituitarism Associated with Polymorphic Psychiatric Symptoms. Taiwanese Journal of Psychiatry 1996;10(2):182-7.  

73. Liu CY, Bai YM, Yang YY, Lin CC, Sim CB, Lee CH. Suicide and Parasuicide in Psychiatric Inpatients: Ten Years Experience at a General Hospital in Taiwan . Psychological Reports 1996; 79:683-690.  

74. Lin CC, Liu CY, Bai YM, Chan CH, Sim CB. Evaluation of Suicide Precaution Procedures in a General Hospital Psychiatric Ward. Taiwanese Journal of Psychiatry 1993; 7(2): 105-12.  

 

沒有留言:

張貼留言